18F-AV-1451 PET Imaging in Subjects With Frontotemporal Dementia
Phase of Trial: Phase I
Latest Information Update: 28 Jul 2017
At a glance
- Drugs Flortaucipir-F-18 (Primary) ; Florbetapir F 18
- Indications Dementia
- Focus Diagnostic use
- Sponsors Avid Radiopharmaceuticals
- 13 Apr 2017 Status changed from not yet recruiting to recruiting.
- 06 Mar 2017 Planned initiation date changed from 1 Feb 2017 to 1 Mar 2017.
- 07 Feb 2017 New trial record